ATE486093T1 - Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt - Google Patents

Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt

Info

Publication number
ATE486093T1
ATE486093T1 AT03756532T AT03756532T ATE486093T1 AT E486093 T1 ATE486093 T1 AT E486093T1 AT 03756532 T AT03756532 T AT 03756532T AT 03756532 T AT03756532 T AT 03756532T AT E486093 T1 ATE486093 T1 AT E486093T1
Authority
AT
Austria
Prior art keywords
pro
probnp
iii
ser
arg
Prior art date
Application number
AT03756532T
Other languages
English (en)
Inventor
Bernard Pau
Isabelle Giuliani
Francois Rieunier
Original Assignee
Bio Rad Pasteur
Centre Nat Rech Scient
Univ Montpellier I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Rad Pasteur, Centre Nat Rech Scient, Univ Montpellier I filed Critical Bio Rad Pasteur
Application granted granted Critical
Publication of ATE486093T1 publication Critical patent/ATE486093T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Cardionatrin; Cardiodilatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT03756532T 2002-08-07 2003-08-07 Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt ATE486093T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0210063A FR2843396B1 (fr) 2002-08-07 2002-08-07 Anticorps specifiques pour le diagnostic de l'insuffisance cardiaque
PCT/FR2003/002483 WO2004014952A2 (fr) 2002-08-07 2003-08-07 Anticorps specifiques du probnp (1-108) pour le diagnostic de l'insuffisance cardiaque

Publications (1)

Publication Number Publication Date
ATE486093T1 true ATE486093T1 (de) 2010-11-15

Family

ID=30470996

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03756532T ATE486093T1 (de) 2002-08-07 2003-08-07 Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt

Country Status (12)

Country Link
US (1) US7553937B2 (de)
EP (1) EP1527101B1 (de)
JP (1) JP4576232B2 (de)
CN (1) CN100467489C (de)
AT (1) ATE486093T1 (de)
AU (1) AU2003282194B2 (de)
CA (1) CA2494140C (de)
DE (1) DE60334696D1 (de)
ES (1) ES2354608T3 (de)
FR (1) FR2843396B1 (de)
RU (1) RU2315773C2 (de)
WO (1) WO2004014952A2 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7524635B2 (en) * 2003-04-17 2009-04-28 Biosite Incorporated Methods and compositions for measuring natriuretic peptides and uses thereof
AT500800B1 (de) * 2004-09-08 2008-07-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
US7300494B2 (en) * 2005-02-24 2007-11-27 Hamilton Sundstrand Corporation On-board inert gas generation system with compressor surge protection
DE102007010834A1 (de) * 2007-03-03 2008-09-04 Brahms Aktiengesellschaft Diagnose und Risikostratifizierung von Herzinsuffizienz für NYHA I Patienten
AT504942B1 (de) 2007-03-07 2009-08-15 Biomedica Medizinprodukte Gmbh Verfahren zur bestimmung von probnp
FR2919611B1 (fr) 2007-08-03 2009-10-23 Bio Rad Pasteur Sa Nouvel epitope du bnp (1-32) et anticorps diriges contre cet epitope
WO2010012509A1 (en) * 2008-08-01 2010-02-04 Bio-Rad Pasteur Method for the in vitro diagnosis of stroke
CN101998965B (zh) * 2007-11-01 2014-03-12 安斯泰来制药有限公司 免疫抑制性多肽与核酸
US9366680B2 (en) * 2008-08-28 2016-06-14 Shimadzu Corporation Method for evaluating myocardial ischemic state using blood sample
WO2010077654A1 (en) * 2008-12-08 2010-07-08 Biosite Incorporated Combined natriuretic peptide assays
AU2009339152B2 (en) * 2009-01-30 2015-11-19 Bio-Rad Europe Gmbh Method for the in vitro diagnosis of stroke
JP5362487B2 (ja) * 2009-08-27 2013-12-11 塩野義製薬株式会社 ｐｒｏＢＮＰ−１０８の新規用途
CN102549429B (zh) 2009-09-14 2015-08-19 皇家飞利浦电子股份有限公司 使用大颗粒标记的高灵敏性免疫测定
US20120021431A1 (en) * 2010-02-25 2012-01-26 Toshio Nishikimi Diagnostic methods using bnp
AU2011285694B2 (en) 2010-08-04 2014-12-18 Idexx Laboratories, Inc. Detection of degradation products of canine NT-proBNP
US8407182B1 (en) 2011-01-21 2013-03-26 Symantec Corporation Systems and methods for facilitating long-distance live migrations of virtual machines
US8527990B1 (en) 2011-04-29 2013-09-03 Symantec Corporation Systems and methods for migrating virtual machines
EP2715353B1 (de) 2011-05-31 2016-08-24 IDEXX Laboratories, Inc. Nachweis von abbauprodukten von felinem nt-probnp
CN102887943B (zh) * 2012-08-30 2016-08-03 重庆业为基生物科技有限公司 氨基末端脑钠肽的b细胞表位肽段及其应用
CN103012595B (zh) * 2012-12-17 2014-05-21 同昕生物技术（北京）有限公司 稳定的NT-proBNP校准品及应用
RU2569458C1 (ru) * 2014-12-02 2015-11-27 Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения России (ФГБУ "РКНПК" МЗ РФ) Способ диагностики хронической сердечной недостаточности путем использования циркулирующих уровней микрорнк
RU2569459C1 (ru) * 2014-12-02 2015-11-27 Федеральное государственное бюджетное учреждение "Российский кардиологический научно-производственный комплекс" Министерства здравоохранения России (ФГБУ "РКНПК" МЗ РФ) Способ дифференциальной диагностики этиологии хронической сердечной недостаточности
US11867696B2 (en) * 2015-02-06 2024-01-09 Cell Idx, Inc. Antigen-coupled immunoreagents
US10368774B2 (en) 2015-07-30 2019-08-06 Medtronic, Inc. Absolute intrathoracic impedance based scheme to stratify patients for risk of a heart failure event
CN105349545A (zh) * 2015-12-14 2016-02-24 中国人民解放军军事医学科学院基础医学研究所 一种NT-proBNP核酸适配体及其应用
US12322100B2 (en) 2018-12-11 2025-06-03 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and grading of aortic stenosis severity
US12001939B2 (en) 2018-12-11 2024-06-04 Eko.Ai Pte. Ltd. Artificial intelligence (AI)-based guidance for an ultrasound device to improve capture of echo image views
US12400762B2 (en) 2018-12-11 2025-08-26 Eko.Ai Pte. Ltd. Automatic clinical workflow that recognizes and analyzes 2D and doppler modality echocardiogram images for automated cardiac measurements and diagnosis of cardiac amyloidosis and hypertrophic cardiomyopathy
US11931207B2 (en) 2018-12-11 2024-03-19 Eko.Ai Pte. Ltd. Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device
US11446009B2 (en) 2018-12-11 2022-09-20 Eko.Ai Pte. Ltd. Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images
CN109678958B (zh) * 2019-01-31 2022-03-18 重庆探生科技有限公司 一种人NT-proBNP特异性重组羊单克隆抗体及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9211686D0 (en) * 1992-06-03 1992-07-15 Medisinsk Innovation A S Chemical compounds
CN1140295C (zh) * 1993-11-05 2004-03-03 森特克公司 血小板特异性的嵌合性免疫球蛋白及其使用方法
DE69733560T2 (de) * 1996-03-04 2006-05-11 Scios Inc., Fremont TESTVERFAHREN UND REAGENZIEN ZUR QUANTIFIZIERUNG VON hBNP
US6828107B2 (en) * 1997-09-11 2004-12-07 Shionogi & Co., Ltd. Immunoassay method for BNP
US6117644A (en) * 1998-06-04 2000-09-12 Ottawa Heart Institute Research Corporation Predicting and detecting cardiac allograft rejection
GB9827348D0 (en) * 1998-12-12 1999-02-03 Univ Leicester Natriuretic peptide
PL204235B1 (pl) * 1999-01-29 2009-12-31 Roche Diagnostics Gmbh Sposób wykrywania natywnego N-końcowego proBNP, zastosowanie tego sposobu, zastosowanie zrekombinowanego N-końcowego proBNP, przeciwciała przeciw zrekombinowanemu N-końcowemu proBNP, linie komórkowe i sposoby wytwarzania przeciwciał poliklonalnych i monoklonalnych
AUPS169202A0 (en) * 2002-04-11 2002-05-16 Goetze, Jens Peter Neuropeptide assay
EP1616181B1 (de) * 2003-04-17 2009-08-12 Vermillion, Inc. Mit natriuretischen peptiden verwandte polypeptide und verfahren zu ihrer identifizierung und verwendung
EP2256132B1 (de) * 2003-05-12 2015-04-01 Roche Diagnostics GmbH Verfahren zum Nachweis von ProBNP mit einem monoklonalen Antikörper
DE10355731A1 (de) * 2003-11-28 2005-06-30 Roche Diagnostics Gmbh Analytischer Sandwichtest zur Bestimmung von NT-proBNP

Also Published As

Publication number Publication date
EP1527101B1 (de) 2010-10-27
EP1527101A2 (de) 2005-05-04
JP4576232B2 (ja) 2010-11-04
AU2003282194A1 (en) 2004-02-25
CA2494140C (fr) 2011-11-01
US7553937B2 (en) 2009-06-30
FR2843396B1 (fr) 2005-04-15
AU2003282194B2 (en) 2008-10-30
CN100467489C (zh) 2009-03-11
WO2004014952A3 (fr) 2004-04-08
WO2004014952A2 (fr) 2004-02-19
CN1678635A (zh) 2005-10-05
FR2843396A1 (fr) 2004-02-13
RU2315773C2 (ru) 2008-01-27
RU2005106230A (ru) 2005-10-10
US20070299016A1 (en) 2007-12-27
ES2354608T3 (es) 2011-03-16
JP2006514609A (ja) 2006-05-11
CA2494140A1 (fr) 2004-02-19
DE60334696D1 (de) 2010-12-09

Similar Documents

Publication Publication Date Title
ATE486093T1 (de) Antikörper, die spezifische für probnp(1-108) sind, und ihre verwendung zur diagnose von herzinfarkt
EP1625163B8 (de) Verfahren zum nachweis von probnp mit einem monoklonalen antikörper, der die amino saüre 38-43 bindet
ATE440868T1 (de) Monoklonaler antikírper gegen ein prion protein und dessen verwendung zum nachweis von prionen
ATE402267T1 (de) Verfahren zur herstellung von monoklonalen antikörpern
NO20013698D0 (no) Fremgangsmåte for identifisering av N-terminalt proBNP
FI3718564T3 (fi) Uusia anti-IL 13 -vasta-aineita ja niiden käyttöjä
DE60014124D1 (de) Antikörper, die spezifisch für fullerene sind
RU2010107618A (ru) Новый эпитоп bnp (1-32) и антитела, направленные против указанного эпитопа
RU2012129732A (ru) Агрегация, зависящая от последовательностей
CN108700576A (zh) 制备抗体对的方法、试剂盒及试剂盒的应用和制备抗体对的系统
RU2008130898A (ru) Антитело против периостина и содержащая его фармацевтическая композиция для профилактики или лечения заболевания, в развитии которого участвует периостин
EP0401370B1 (de) Enzymimmuntest für menschliches typiv-collagen gemäss dem sandwichverfahren
ATE390443T1 (de) Monoklonale antikörper zur selektiven immunologischen bestimmung von hochmolekularen, intakten lamininformen in körperflüssigkeiten
DK165955C (da) Monoklonale antistoffer mod atriale, natriuretiske peptider hos pattedyr, hybridomcellelinier, der producerer antistofferne, fremgangsmaade til fremstilling af antistofferne, fremgangsmaade til fremstilling af hybridomcellerne og anvendelse af antistofferne
CN119684448B (zh) 抗Ki-67蛋白的单克隆抗体及其应用
CN119638830B (zh) 针对人s100a7蛋白的抗体、抗体对和试剂盒及其用途
CN120058924B (zh) 抗人角蛋白8的抗体、抗体偶联物及其应用
CN120699156A (zh) 抗人胃蛋白酶原i的抗体和抗体对及检测试剂盒
CN120209131A (zh) 针对人krt19的单克隆抗体和其应用
CN119490597A (zh) 抗人IgM的抗体或其功能性片段及其应用
CN121319193A (zh) 抗末端脱氧核苷酸转移酶的抗体和其应用
CN111100202A (zh) 针对蛋白标签Streptactin的人源单克隆抗体
ATE382639T1 (de) Anti-humane thymidylat-synthase monoklonale antikörper und hybridomazellen zu deren herstellung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1527101

Country of ref document: EP

EEFA Change of the company name